Dialysis adequacy and health related quality of life in hemodialysis patients

ASAIO Journal

Volumn 48, Issue 5, 2002, Pages 565-569

  Manns, Braden J ^a   Johnson, Jeffrey A ^a   Taub, Ken ^a   Mortis, Garth ^a   Ghali, William A ^a   Donaldson, Cam ^a  

^a FOOTHILLS HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH; HEMODIALYZERS; REGRESSION ANALYSIS;

DIALYSIS ADEQUACIES;

DIALYSIS;

ADULT; AGED; ARTICLE; CALCULATION; COMPUTER PROGRAM; DEMOGRAPHY; FEMALE; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FAILURE; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; QUALITATIVE ANALYSIS; QUALITY OF LIFE; SCORING SYSTEM; STATISTICAL ANALYSIS;

EID: 0036739205     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002480-200209000-00021     Document Type: Article

References (32)

1. Harnett JD, Kent GM, Foley RN, Parfrey PS: Cardiac function and hematocrit level. Am J Kidney Dis (Suppl) 25: 3-7, 1995.
2. Gudex CM: Health-related quality of life in endstage renal failure. Qual Life Res 4: 359-366, 1995.
3. Gokal R: Quality of life in patients undergoing renal replacement therapy. Kidney Int (Suppl) 40: 23-27, 1993.
4. Hays RD, Kallich JD, Mapes DL, Coons SJ, Carter WB: Development of the kidney disease quality of life (KDQOL) instrument. Qual Life Res 3: 329-338, 1994.
5. de Wit GA, Ramsteijn PG, de Charro FT: Economic evaluation of end stage renal disease treatment. Health Policy 44: 215-232, 1998.
6. Churchill DN, Torrance GW, Taylor DW, et al: Measurement of quality of life in end-stage renal disease: The time trade-off approach. Clin Invest Med 10: 14-20, 1987.
7. Merkus MP, Jager KJ, Dekker FW, Boeschoten EW, Stevens P, Krediet RT: Quality of life in patients on chronic dialysis: Self-assessment 3 months after the start of treatment. The Necosad Study Group. Am J Kidney Dis 29: 584-592, 1997.
8. Merkus MP, Jager KJ, Dekker FW, De Haan RJ, Boeschoten EW, Krediet RT: Quality of life over time in dialysis: The Netherlands Cooperative Study on the Adequacy of Dialysis. NECOSAD Study Group. Kidney Int 56: 720-728, 1999.
9. Canadian Erythropoietin Study Group: Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. BMJ 300: 573-578, 1990.
10. Tawney KW, Tawney PJ, Hladik G, et al: The life readiness program: a physical rehabilitation program for patients on hemodialysis. Am J Kidney Dis 36: 581-591, 2000.
11. Kutner NG, Zhang R, McClellan WM: Patient-reported quality of life early in dialysis treatment: Effects associated with usual exercise activity. Nephrol Nurs J 27: 357-367, 2000.
12. Laupacis A, Keown P, Pus N, et al: A study of the quality of life and cost-utility of renal transplantation. Kidney Int 50: 235-242, 1996.
13. Powers KM, Wilkowski MJ, Helmandollar AW, Koenig KG, Bolton WK: Improved urea reduction ratio and Kt/V in large hemodialysis patients using two dialyzers in parallel. Am J Kidney Dis 35: 266-274, 2000.
14. Guyatt GH, Feeny DH, Patrick DL: Measuring health-related quality of life. Ann Intern Med 118: 622-629, 1993.
15. Drummond M, O'Brien B, Stoddart G, Torrance G: Methods for the economic evaluation of health care programmes, 2nd ed. Oxford University Press, 1997
16. Kind P, Dolan P, Gudex C, Williams A: Variations in population health status: Results from a United Kingdom national questionnaire survey. BMJ 316: 736-741, 1998.
17. Johnson JA, Coons SJ: Comparison of the EQ-5D and SF-12 in an adult US sample. Qual Life Res 7: 155-166, 1998.
18. Johnson JA, Coons SJ, Ergo A, Szava-Kovats G: Valuation of EuroQOL (EQ-5D) health states in an adult US sample. Pharmacoeconomics 13: 421-433, 1998.
19. Johnson JA, Pickard AS: Comparison of the EQ-5D and SF-12 health surveys in a general population survey in Alberta, Canada. Med Care 38: 115-121, 2000.
20. Canadian Coordinating Office for Health Technology Assessment: Guidelines for Economic evaluation of pharmaceuticals, 2nd ed. Ottawa, Canada: 1997.
21. Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 40: 373-383, 1987.
22. Beddhu S, Bruns FJ, Saul M, Seddon P, Zeidel ML: A simple comorbidity scale predicts clinical outcomes and costs in dialysis patients. Am J Med 108: 609-613, 2000.
23. NKF-DOQI: Clinical practice guidelines for hemodialysis adequacy. National Kidney Foundation. Am J Kidney Dis (Suppl) 30: 15-66, 1997.
24. Garred L, McCready W: A new simple formula for calculating based on urea kinetic modeling theory. Blood Purif 10: 90A, 1992.
25. Gotch FA, Sargent JA: A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 28: 526-534, 1985.
26. Wight JP, Edwards L, Brazier J, Walters S, Payne JN, Brown CB: The SF36 as an outcome measure of services for end stage renal failure. Qual Health Care 7: 209-221, 1998.
27. Dolan P: Modeling valuations for EuroQol health states. Med Care 35: 1095-1108, 1997
28. Maor Y, King M, Olmer L, Mozes B: A comparison of three measures: The time trade-off technique, global health-related quality of life and the SF-36 in dialysis patients. J Clin Epidemiol 54: 565-570, 2001.
29. Morton AR, Meers C, Singer MA, et al: Quantity of dialysis: Quality of life-what is the relationship? ASAIO J 42: M713-717, 1996.
30. Merkus MP, Jager KJ, Dekker FW, de Haan RJ, Boeschoten EW, Krediet RT: Physical symptoms and quality of life in patients on chronic dialysis: results of The Netherlands Cooperative Study on Adequacy of Dialysis (NECOSAD). Nephrol Dial Transplant 14: 1163-1170, 1999.
31. DeOreo PB: Hemodialysis patient-assessed functional health status predicts continued survival, hospitalization, and dialysis-attendance compliance. Am J Kidney Dis 30: 204-212, 1997.
32. Brissenden J, Pierratos A, Ouwendyk M, Roscoe J: Improvements in quality of life with nocturnal hemodialysis (Abstract). J Am Soc Nephrol 9: 168A, 1998.